Research Snapshot: Compounds may overcome drug resistance in prostate cancer
The findings indicate that two DNA-damaging compounds may be able to overcome resistance to drugs used to treat advanced-stage prostate cancer.
All Posts by
The findings indicate that two DNA-damaging compounds may be able to overcome resistance to drugs used to treat advanced-stage prostate cancer.
Check out CaRE2 presentations at the AACR Conference on The Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved.
Researchers bolstered their findings that kava may reduce lung cancer risk caused by tobacco smoke.
Devika Das cares for patients with thoracic malignancies such as lung cancer and works to boost lung cancer screening rates.
With a grant from the nonprofit Teen Cancer America, the UF Health Adolescent and Young Adult Cancer program will expand.
Carolyn M. Tucker, Ph.D., was recognized for her research, leadership and commitment to her work, her community and to her field.
Researchers identified a novel mechanism in the epigenome that could pave the way to develop new therapies for multiple myeloma.
Arinola Lampejo's research explores vessel plasticity in the tumor microenvironment.
A UF team secured a provisional patent for a groundbreaking device that addresses the challenges of total skin electron beam therapy.
The project will study the role of myeloid cells in nanotherapeutic treatments of diseases like cancer, sepsis, and autoimmune disorders.